SCHEMBL7519636

SCHEMBL7519636

CC(C)n1ccc(=O)n(Cc2ccccc2)c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.52
HPGD P15428 1/20 0.48
CYP3A4 P08684 1/20 0.44
GSK3A P49840 4/20 0.44
GSK3B P49841 4/20 0.44
CCNB2 O95067 1/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNB3 Q8WWL7 1/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PRKCA P17252 1/20 0.42
MEN1 O00255 1/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
P2RX4 Q99571 1/20 0.40
RGS4 P49798 2/20 0.40
RGS8 P57771 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7512200 0.84 KMT2A (0.47) KMT2AHPGDCYP3A4GSK3AGSK3B
SCHEMBL7466508 0.78 HPGD (0.55) KMT2AHPGDCYP3A4GSK3AGSK3B
SCHEMBL14600369 0.77 KMT2A (0.45) KMT2AHPGDKDM4EMAPTMEN1
SCHEMBL5800712 0.76 HPGD (0.49) KMT2AHPGDCYP3A4GSK3AGSK3B
SCHEMBL1584773 0.75 HPGD (0.47) KMT2AHPGDCYP3A4GSK3AGSK3B
SCHEMBL7750738 0.75 HPGD (0.51) KMT2AHPGDCYP3A4GSK3AGSK3B
SCHEMBL30272686 0.73 HPGD (0.50) KMT2AHPGDCYP3A4GSK3AGSK3B
SCHEMBL8985073 0.72 GSK3B (0.67) KMT2AHPGDCYP3A4GSK3AGSK3B
SCHEMBL19377760 0.71 GSK3B (0.46) KMT2ACYP3A4GSK3AGSK3BKDM4E
SCHEMBL7521742 0.71 HTT (0.45) KMT2AHPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107778254-A The synthetic method of the pyrimidine derivatives of Internmediate of anti viral medicine oxo two 陈国妃 2018-03-09 CN disclosed
CN-1352637-A Process for preparing MKC-442 TRIANGLE PHARMACEUTICALS INC (US) 2002-06-05 CN disclosed
EP-1169310-A1 PROCESS FOR PREPARING MKC-442 Triangle Pharmaceuticals Inc. (US) 2002-01-09 EP disclosed
EP-1169310-A1 PROCESS FOR PREPARING MKC-442 Triangle Pharmaceuticals Inc. (US) 2002-01-09 EP disclosed
WO-2000061566-A1 PROCESS FOR PREPARING MKC-442 TRIANGLE PHARMACEUTICALS, INC. (US) 2000-10-19 WO disclosed
WO-2000061566-A1 PROCESS FOR PREPARING MKC-442 TRIANGLE PHARMACEUTICALS, INC. (US) 2000-10-19 WO disclosed